We are live on ! Find out more
EOLS icon

Evolus

104 hedge funds and large institutions have $133M invested in Evolus in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more call options, than puts

Call options by funds: $3.04M | Put options by funds: $2.06M

24% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 29

4.72% more ownership

Funds ownership: 32.3%37.02% (+4.7%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less capital invested

Capital invested by funds: $135M → $133M (-$1.67M)

8% less funds holding

Funds holding: 113104 (-9)

28% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 25

Holders
104
Holders Change
-9
Holders Change %
-7.96%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
36
Reduced
29
Closed
25
Calls
$3.04M
Puts
$2.06M
Net Calls
+$984K
Net Calls Change
-$984K
Name Holding Trade Value Shares
Change
Change in
Stake
First Manhattan
1
First Manhattan
New York
$21.7M +$8.95M +1,305,009 +64%
Schroder Investment Management Group
2
Schroder Investment Management Group
United Kingdom
$15.1M +$4.36M +636,109 +38%
BlackRock
3
BlackRock
New York
$14.5M +$374K +54,531 +3%
SCM
4
Stonepine Capital Management
Oregon
$12.1M +$10.7M +1,563,096 +521%
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.3M +$303K +44,128 +3%
SCM
6
Soleus Capital Management
Connecticut
$8.2M +$4.23M +615,955 +96%
N
7
Nuveen
North Carolina
$5.14M +$728K +106,052 +13%
AC
8
AWH Capital
Texas
$4.88M +$443K +64,500 +9%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$4.56M +$289K +42,087 +6%
State Street
10
State Street
Massachusetts
$4.37M -$52.7K -7,676 -1%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$3.83M +$98.5K +14,363 +3%
GCM
12
Glenview Capital Management
New York
$2.56M +$2.7M +393,827 New
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$2.02M +$2.13M +310,600 New
Northern Trust
14
Northern Trust
Illinois
$2.02M +$11.3K +1,643 +0.5%
Goldman Sachs
15
Goldman Sachs
New York
$1.96M +$66.1K +9,641 +3%
Charles Schwab
16
Charles Schwab
California
$1.11M
MPAM
17
Monarch Partners Asset Management
Massachusetts
$1.08M +$96.5K +14,059 +9%
Federated Hermes
18
Federated Hermes
Pennsylvania
$1.05M -$926 -135 -0.1%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$943K -$332K -48,323 -25%
PCM
20
Potomac Capital Management
New York
$863K +$909K +132,500 New
AQR Capital Management
21
AQR Capital Management
Connecticut
$832K +$82.7K +12,055 +10%
Citadel Advisors
22
Citadel Advisors
Florida
$829K -$1.83M -266,894 -68%
BFM
23
Boothbay Fund Management
New York
$721K
Bank of New York Mellon
24
Bank of New York Mellon
New York
$688K +$12.7K +1,847 +2%
BGIM
25
Brandywine Global Investment Management
Pennsylvania
$681K -$19.9K -2,900 -3%

EOLS Hedge Fund Activity: Q4 2021 in Review

104 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q4 2021, worth a combined $133M — down 1.2% from $135M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of EOLS and 18 opened new positions — a net loss of 7 holders — while 29 trimmed existing stakes and 36 added.

The largest buyer was Stonepine Capital Management, adding an estimated $10.7M. The largest seller was Maven Securities, exiting entirely with an estimated $4.27M sold.

  • 104 institutional investors held Evolus (EOLS) as of Q4 2021, down from 113 in Q3 2021.
  • Funds reported $133M of Evolus stock for Q4 2021, down 1.2% quarter-over-quarter.
  • 18 funds opened new Evolus positions in Q4 2021 and 25 closed out, a net change of -7 holders.
  • The largest Evolus buyer in Q4 2021 was Stonepine Capital Management, an estimated $10.7M added.
  • The largest Evolus seller in Q4 2021 was Maven Securities, an estimated $4.27M sold.

Based on aggregated 13F filings for Q4 2021.